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Abstract We report the regulation of cGMP accumulation 
induced by the heat-stable enterotoxin, STh, in the T84 human 
colonic cell line. STh binding to its receptor, guanylyl cyclase C 
(GCC), leads to elevated intracellular levels of cGMP. 
Prolonged exposure of T84 cells to STh induced refractoriness 
to further cGMP accumulation, without significant receptor 
internalization, but with reduced STh-induced cGMP synthesis 
by the receptor. Significantly, increased degradation of cGMP 
by a cGMP-specific phosphodiesterase was observed in desensi-
tized cells. This is the first report on the desensitization of GCC, 
as well as the role of the Type V phosphodiesterase in inducing 
cellular refractoriness. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The heat-stable enterotoxins (ST) are a family of low mo-
lecular weight, methanol soluble, cysteine rich peptides, pro-
duced by E. coli and other pathogenic bacteria, that cause 
diarrhea in farm animals and in man [1]. Binding of the toxin 
to a receptor present in intestinal cells leads to elevation of 
intracellular cGMP and a consequent efflux of chloride and 
fluid from the cells, resulting in diarrhea [2]. The receptor for 
E. coli STh, GCC, has been cloned from rat and human in-
testinal cells [3,4], as well as from human colonic cell lines [5]. 
Based on sequence homology studies predicted from the nu-
cleotide sequence of the cloned ST receptors, the ST receptor 
(GCC) is a member of the family of membrane bound gua-
nylyl cyclases [6]. 
A characteristic feature of any ligand receptor-mediated 
signal transduction process is the phenomenon of desensitiza-
tion whereby cellular response to a stimulus is attenuated, or 
demonstrates refractoriness, following prior exposure of the 
cells to the ligand in question. ST-mediated diarrheas are 
transitory in nature, but the mechanism of this refractoriness, 
presumably induced in the intestinal cells which have been 
exposed to ST peptide, is unknown. Whether such refractori-
ness involves receptor desensitization, or other intracellular 
mechanisms has not been investigated till date. 
*Corresponding author. Fax: (91) (80) 3341683. 
Abbreviations: cGB-PDE, cGMP-binding, cGMP-specific phospho-
diesterase; GCC, guanylyl cyclase C; PDE, phosphodiesterase; IBMX, 
isobutyl methyl xanthine; STh, stable toxin of the human variety; 
STY72F, mutant ST peptide where the C-terminal tyrosine is mutated 
to phenylalanine 
Cellular refractoriness to a given stimulus could be medi-
ated by an altered rate of synthesis or degradation of the 
second messenger, for example cAMP or cGMP. Synthetic 
rates are presumably regulated by the receptor, which in the 
case of guanylyl cyclase coupled receptors, serves as the en-
zyme per se. The rate of degradation of cAMP has been 
shown to play an important role in inducing the refractoriness 
of Sertoli cells to follicle stimulating hormone [7], by the hy-
peractivation of a cAMP-specific phosphodiesterase (PDE). 
No such mechanism of regulation has been reported, to our 
knowledge, for cGMP-mediated mechanisms, and hence the 
ST response in T84 cells could serve as a useful model system 
to study such cellular refractoriness. 
The T84 cell line has been used by us to study the STh 
receptor, and we have shown that a single class of receptor 
with high affinity (K¿ 0.1 nM) is expressed in these cells [8,9]. 
In this study we report that T84 cells show refractoriness to 
fresh stimulation by ST, following prolonged incubation with 
the peptide. This refractoriness is at the level of the degrada-
tion of the second messenger, cGMP, as a result of increased 
activity of a cGMP-specific PDE, as well as receptor inacti-
vation at the level of guanylyl cyclase activity. 
2. Materials and methods 
All fine chemicals were from Sigma Chemical Co., USA, and tissue 
culture media from Life Technologies, USA. 
2.1. Culture and maintenance of T84 cells 
T84 cells were obtained from ATCC (CCL 247), and maintained in 
Dulbecco's Modified Eagle's medium:F12 containing 5% new born 
calf serum, penicillin and streptomycin as described in detail earlier 
[8]. Cells were plated in 24-well culture dishes at a concentration of 
104 cells/well, and were used at approximately 75-90% confluency, 
after 4-7 days in culture. 
2.2. Purification and radiolabeling of ST peptides 
STh peptide was purified from the culture supernatant of E. coli 
cells which overproduced the toxin, as described earlier [10]. Purified 
peptides were quantitated by aminoacid analysis [11]. An analog of 
STh, STY72F, was used as the radioligand for receptor-binding anal-
ysis, and was prepared as reported earlier in detail [9]. The specific 
activity of the radiolabeled STY72F was 2000 Ci/mmol, and the ra-
diolabeled peptide was used within a month of preparation. 
2.3. Desensitization of T84 cells 
Cells were grown to confluence in 24-well plates and incubated with 
the STh (3 X 10~7 M) for 18 h in serum-free DMEM:F12 at 37°C in a 
5% CO2 humidified incubator. Wells were washed thrice with warm, 
serum-free medium and incubated with the same medium in the ab-
sence of any PDE inhibitor, or in the presence of either 1 mM IBMX, 
or the specific PDE inhibitors zaprinast, phenothiazine, milrinone or 
Ro 20-1724 (50 μΜ), for 30 min at 37°C. Cells were then restimulat-
ed for 15 min at 37°C with STh (3xl0 - 7 M) and the reaction 
was terminated by aspiration of media and addition of 0.1 M citric 
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acid to each well. Cells were lysed, and cGMP in the lysates meas-
ured without succinylation of the samples by radioimmunoassays us-
ing 125I-labeled cGMP prepared as described previously [12]. Stimu-
lation for 15 min with this concentration of STh produce low or 
undetectable levels of cGMP in the extracellular medium of the cells 
[8]. 
2.4. Preparation of membranes from T84 cells and guanylyl cyclase 
assays 
Membranes were prepared from cell lysates (100000 g pellet) of 
confluent cultures of T84 cells, following prior exposure of mono-
layers to STh (3X 10~7 M) or medium [9], and used for the measure-
ment of labeled STY72F-binding activity as well as guanylyl cyclase 
activity. To monitor the receptor in membranes prepared from control 
and desensitized cells, membrane protein (50 μg) was incubated with 
radiolabeled STY72F peptide (10~10 M) in the presence or absence of 
unlabeled STh (10~7 M) as described earlier, [9], and then filtered 
through GF/C filters. For in vitro guanylyl cyclase assays, membrane 
protein (50 μg) was incubated in the presence or absence of STh (10~6 
M) in 60 mM Tris-HCl buffer, pH 7.6, along with 4 mM MgCl2, 
2 mM GTP, 500 μΜ ΙΒΜΧ and a GTP regenerating system consist-
ing of 20 μg creatine phosphokinase and 7.5 mM creatine phosphate. 
In some cases, membranes were treated with 0.3% Lubrol-PX for 10 
min at 25°C before addition of substrate. MnCl2 (4 mM), which is 
known to activate the receptor non-specifically [13] was also used in 
some cases instead of MgCl2. Incubations were continued for 10 min 
at 37°C and the reaction terminated by the addition of 400 ml of 50 
mM sodium acetate buffer, pH 4.5. Samples were heated in a boiling 
water bath for 10 min, and the supernatant taken for assay of cGMP. 
2.5. In vitro PDE assays 
Cells were cultured in 24-well dishes and exposed to STh (3 X 10~7 
M) for 18 h. Cell monolayers were washed in serum-free medium, and 
harvested in 50 mM Tris-HCl, pH 7.5, containing 1 μg/ml leupeptin, 
1 mM benzamidine, 2 mM EDTA, 10 nM okadaic acid, 10 mM 
sodium vanadate and 5 mM 2-mercaptoethanol. The cells were ho-
mogenized and homogenates were used for assay of PDE activity, in 
the absence or presence of zaprinast (20 μΜ). The assay was per-
formed essentially as described earlier, with some modifications 
[14,15]. Assay mixtures contained 50 mM Tris-HCl buffer, pH 8.0, 
containing 10 mM MgCl2, 300 μg/ml bovine serum albumin and 
150000-200000 cpm 3H-cGMP (0.2 μΜ) (New England Nuclear, 
USA) which had been purified earlier by ion exchange chromatogra-
phy [16]. Assays were conducted for 15 min at 30°C, following which 
the samples were boiled for 5 min. Crotalus vulgaris snake venom 
toxin was added (20 μg/tube), and incubation continued for a further 
30 min. 3H-guanosine generated was monitored by ion exchange chro-
matography through DEAE-Sephadex A-25, which had been equil-
ibrated with 20 mM ammonium formate [16]. 
3. Results 
Application of STh to T84 cells leads to a rapid elevation of 
intracellular cGMP in cells, which declines 3 h following ad-
dition of STh [8]. We exposed T84 cells to STh for 18 h and 
then restimulated the cells with fresh peptide. The intracellular 
levels of cGMP at the end of 18 h were low, and addition of 
fresh STh did not lead to a significant increase in intracellular 
cGMP levels (Fig. 1A), indicating cellular desensitization. 
High levels ( > 500 pmol) of cGMP were detected in the ex-
tracellular medium, indicating that the cells had responded to 
STh over 18 h, and much of the cGMP produced during that 
time had been secreted by the cells. The low intracellular levels 
of cGMP after 18 h of incubation with STh could be due to 
degradation of STh over 18 h. We therefore compared cGMP 
production induced by STh present in the spent medium of 
cells which had been exposed to STh for 18 h, with that 
following application of fresh STh. As can be seen in Fig. 
IB, no significant difference in the levels of cGMP production 
was observed, indicating that low levels of cGMP within cells 
following 18 h incubation with STh could not be attributed to 
degradation of peptide during the period of the incubation. 
To detect receptor internalization and degradation as a 
means of contributing to the desensitization of T84 cells, we 
monitored radiolabeled STY72F binding to membranes pre-
pared from control and desensitized cells. Results showed no 
significant reduction in the binding in desensitized membranes 
when compared to the control membranes (Fig. 2A; P>0.1) , 
and therefore a reduction in total receptor content could not 
account for the >90% reduction in cGMP accumulation in 
desensitized cells. This suggested that intracellular changes, 
either at the level of synthesis or degradation of cGMP, had 
occurred in T84 cells resulting in the refractoriness to further 
STh stimulation. 
We first investigated GCC desensitization in terms of its 
ability to synthesize cGMP and performed in vitro guanylyl 
cyclase assays with membranes prepared from control and 
desensitized cells. Detergents are known to be non-specific 
activators of membrane associated guanylyl cyclases, even in 
the absence of ligand and this has also been observed in the 
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Fig. 1. Homologous desensitization of the T84 cells. A: Confluent monolayers of T84 cells were incubated with STh (3xl0~7 M) for 18 h. 
Cells were washed and cGMP levels monitored with or without restimulation with STh (3X10-7 M). Control cells were incubated in medium 
without serum and basal cGMP levels measured directly, or on stimulation with STh. Values represent the mean ± S.D. of duplicate determina-
tions with each experiment repeated thrice. B: To check the degradation of STh peptide remaining in the culture supernatant, confluent T84 
cells were stimulated with (1) STh (3x 10~7 M), (2) STh remaining in the culture supernatant after 18 h incubation with T84 cells and (3) STh 
incubated at 37°C without cells for 18 h. cGMP was monitored by radioimmunoassay. Values represent the mean ± S.D., with each experiment 
repeated twice and each well assayed in duplicate. *: P>0.5 when compared with 1. 
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Fig. 2. GCC activity in desensitized cells. Confluent monolayers were preincubated either in the absence (open bars) or presence (closed bars) 
of STh (3X10-7 M) for 18 h, prior to membrane preparation. Membrane protein (50 μg) was used for binding assays or in vitro guanylyl cy-
clase assays. A: Membrane protein was incubated with 125I-labeled STY72F (100000 cpm) for 1 h in the absence or presence of STh (10~7 M) 
unlabeled STh peptide, and receptor associated radioactivity monitored following filtration. Values represent the mean ± S.D. of triplicate deter-
minations with each assay repeated twice. B: Membranes were treated with 0.3% Lubrol-PX for 10 min prior to addition of MgGTP, or 
treated with MnGTP independently. Values represent the mean ± S.D. of duplicate determinations with each experiment repeated twice. 
C: Membrane protein was treated with STh (10~e M) and cGMP produced was monitored. Values represent the mean± S.D. of duplicate de-
terminations with each experiment repeated twice. *: P< 0.001. 
from control and desensitized cells with Lubrol-PX (0.3%) 
and then monitored guanylyl cyclase activity. As shown in 
Fig. 2B, detergent treated membranes prepared from desensi-
tized cells demonstrated no significant reduction in guanylyl 
cyclase activity (P>0.7) . Membranes prepared from desensi-
tized cells also did not show any difference in guanylyl cyclase 
activity in the presence of MnGTP, another non-specific acti-
vator of membrane associated guanylyl cyclase [13]. These 
results indicate that the general guanylyl cyclase catalytic ac-
tivity of the receptor is retained on desensitization. It is perti-
nent to mention here that in T84 cells, the only membrane 
associated guanylyl cyclase activity observed is that of GCC 
[8]. 
We then investigated the sensitivity of GCC to STh stim-
ulation in membranes prepared from control and desensitized 
cells. As shown in Fig. 2C, basal activities in both membrane 
preparations remained similar. However, STh-stimulatable 
guanylyl cyclase activity was significantly reduced to nearly 
50% of control values, in desensitized cells (P< 0.001), and 
STh addition only marginally increased cGMP production 
over basal values. This indicates that an important contribu-
tion to cellular refractoriness is receptor desensitization in 
terms of a reduced sensitivity of the receptor to STh. 
A reduction in the accumulation of cGMP in desensitized 
cells could also be contributed by an increased rate of degra-
dation of cGMP in desensitized T84 cells. A large family of 
PDEs are found in various cell types and while some are 
specific for cAMP or cGMP, others are dual specific and 
degrade both cGMP and cAMP with near equal efficiency 
[17-19]. A number of specific inhibitors are available for the 
various classes of PDEs, which allow the identification of a 
specific PDE responsible for cAMP or cGMP degradation. 
We therefore stimulated desensitized and control cells with 
STh, in the presence and absence of the general PDE inhib-
itor, IBMX, as well as inhibitors for the Ca+-calmodulin-de-
pendent PDE (phenothiazine), the cGMP-inhibited PDE (mil-
rinone), the cAMP-specific PDE (Ro 20-1724 and zaprinast 
(cGMP-specific PDE) [17]. The results shown in Fig. 3 indi-
cate that restimulation of desensitized cells in the presence of 
IBMX restored cGMP accumulation close to levels observed 
in control cells. Interestingly, only zaprinast, a specific inhib-
itor of the cGMP-binding, cGMP-specific (Type V) PDE, 
when added to desensitized cells prior to ST restimulation, 
could restore cGMP levels to those observed with IBMX, 
clearly indicating that the increased activity of this specific 
Type V PDE was responsible for the efficient degradation of 
cGMP in desensitized cells. No specific inhibitor is available 
for the cGMP-stimulated PDE, but our results with zaprinast 
suggest that a major contribution to enhanced cGMP degra-
Fig. 3. Role of phosphodiesterases in inducing refractoriness to STh 
in T84 cells. Confluent monolayers were preincubated without or 
with STh (3X10~7 M) for 18 h. Cells were washed, incubated with 
no phosphodiesterase inhibitor, 1 mM IBMX or specific inhibitors 
as indicated (50 μΜ) for 30 min and restimulated with STh. cGMP 
levels were monitored and values represent the mean ± S.D. of tripli-
cate experiments with each well treated in duplicate. *: P>0.5. 
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Fig. 4. In vitro phosphodiesterase activity in desensitized cells. 
Monolayers of T84 cells were incubated in serum-free medium either 
in the absence or presence of STh (3xl0~7 M) for 18 h at 37°C. 
Cells were washed with serum-free medium and lysed as described 
in experimental procedures. Cell extracts prepared from desensitized 
and control cells were then used to perform in vitro PDE assays, 
in the presence or absence of 10 μΜ zaprinast. Values represent 
the mean of duplicate determinations of three experiments ± S.D. 
*: P<0.001. 
dation in desensitized cells is through the Type V PDE. To 
our knowledge, this is the first report on the contribution of 
enhanced PDE activity towards inducing refractoriness in any 
cGMP-mediated system, and also the first report on the role 
of the Type V PDE in regulating cGMP degradation in a 
cGMP responsive cell in this manner. 
The increased PDE activity observed in vivo should be 
detectable in cell extracts prepared from desensitized cells. 
We therefore prepared cell homogenates from control and 
desensitized cells and measured PDE activity in the extracts. 
As shown in Fig. 4, the activity observed in desensitized cell 
extracts is 2-fold higher than in control cells. This albeit mod-
est increase in activity could nevertheless be significant in 
vivo, when coupled with reduced receptor activity in terms 
of synthesizing cGMP (Fig. 2). The enhanced enzyme activity 
observed in desensitized cells was inhibited by zaprinast, con-
firming that the major PDE activity we have measured is 
contributed by the Type V cGMP-specific PDE (Fig. 4). 
4. Discussion 
In this report, we demonstrate that the human colonic T84 
cell line is refractory to prolonged exposure to the ST pep-
tides, and this refractoriness is a result of receptor desensiti-
zation and the increased activity of a cGB-PDE. To our 
knowledge, the only other well documented report on the 
hyperactivation of a PDE inducing refractoriness in a cell is 
the observation that prolonged exposure of follicle stimulating 
hormone to Sertoli cells reduces the ability of these cells to 
respond to the hormone in terms of cAMP accumulation [7]. 
This refractoriness is brought about by the activation of a 
specific cAMP PDE, the Type IV PDE [21,22], and increased 
activity was detected in crude lysates prepared from cells. 
Hyperactivation in the case of the Type IV enzyme is through 
the increased transcription of the mRNA for this enzyme, and 
possibly also phosphorylation [22]. A second example indi-
cates a rapid regulation of the cAMP-specific PDE by forsko-
lin and isoproterenol in astroglial cells, where the increase in 
enzyme activity in the cytosol of cells is also of the order of 2-
fold, as we have seen in the case of the Type V PDE [23], 
through a mechanism involving changes in the phosphoryla-
tion of the Type IV enzyme. 
Till date, the human cDNA for the Type V enzyme has not 
been cloned, and the only available cDNA for this enzyme 
represents the enzyme present in the bovine lung [24]. 
Whether this bovine cDNA has homology to the human 
gene is not known, and we are presently investigating such 
a possibility. This should allow us to investigate regulation of 
the enzyme activity at the level of transcription. The bovine 
enzyme has consensus sites for phosphorylation by cAMP-
dependent kinase [24]. Changes in the phosphorylation of 
the Type V enzyme could also contribute to the increased 
PDE activity observed in desensitized cells, and it has been 
shown that phosphorylation of the Type V PDE by protein 
kinase A in vitro leads to an increase in the Vmax [15] of the 
enzyme. Whether this occurs in T84 cells remains to be inves-
tigated. 
We have shown here that there is a significant reduction in 
the STh-stimulatable guanylyl cyclase activity of the receptor 
following exposure to ST peptide, with a marked reduction in 
sensitivity to STh, if one considers basal activities in control 
and desensitized cells. However, in whole cells, STh-stimu-
lated cGMP levels seem to approach control values when 
desensitized cells were restimulated in the presence of IBMX 
and zaprinast (Fig. 3). This suggests low receptor desensitiza-
tion in intact cells, which could be due to reactivation of the 
receptor by additional cellular machinery. The receptor gua-
nylyl cyclases appear to be desensitized by a mechanism of 
dephosphorylation of the receptor, perhaps through the in-
volvement of a specific phosphatase [25,26]. In the case of 
the receptor for the atrial natriuretic factor, receptor internal-
ization has also been observed in certain cells [27]. More re-
cently, there is evidence of a cGMP-mediated reduction in the 
level of the receptor mRNA in cells exposed to the atrial 
natriuretic peptide for prolonged periods of time [28]. Our 
report is the first to suggest that the ST receptor is desensi-
tized but we do not find a significant degree of internalization 
of the receptor in T84 cells. This is in agreement with a recent 
report indicating efficient internalization and recycling of the 
receptor in T84 cells along with the ST peptide, without deg-
radation of either the receptor or the peptide [29]. Whether 
the reduction in receptor sensitivity to STh that we have ob-
served is correlated with a change in the phosphorylation of 
the receptor remains to be investigated. We have recently 
generated polyclonal antibodies to the extracellular domain 
of the receptor which should prove useful in such studies [30]. 
Stable toxin diarrheas have been observed to be transitory 
in vivo [20]. Thus, in the only valid in vivo assay for the ST 
peptides, the suckling mouse assay, fluid accumulation in the 
intestine of the suckling mouse is observed maximally 3 h 
following ST administration after which there is a gradual 
decline in the fluid content of the intestine [20]. We suggest 
that the enhanced degradation of the cGMP occurring in in-
testinal cells reported here, could contribute along with recep-
tor desensitization, to the decline in fluid secretion, perhaps at 
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the level of chloride secretion. It remains to be seen whether 
the refractoriness that we observe in terms of c G M P produc-
tion is reflected at the level of chloride secretion in desensi-
tized cells. Our results indicate that the regulation of c G M P 
accumulation in the intestinal cell could be through its degra-
dation rather than its synthesis by the receptor. This may be 
an essential requirement, since guanylin [31], the endogenous 
ligand for G C C , mediates its action through the same recep-
tor. Hence a major decrease in ST receptor activity would 
curtail guanylin action in maintaining and regulating ion ho-
meostasis in the intestine. 
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